Xin F Z, Fan J G
Department of Gastroenterology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
Zhonghua Gan Zang Bing Za Zhi. 2016 Jun;24(6):403-5. doi: 10.3760/cma.j.issn.1007-3418.2016.06.002.
Nonalcoholic fatty liver disease (NAFLD) is a pathological manifestation of obesity and metabolic syndrome involving the liver. It can cause disability and mortality related to liver disease, and it is closely associated with the high incidence rates of type 2 diabetes and cardiovascular diseases. At present, NAFLD has become the most common chronic liver disease worldwide, and the development and implementation of the clinical guideline for the diagnosis and treatment of NAFLD help to improve patients' prognosis. This article provides an interpretation of the latest Europeans guidelines through a comparative analysis of the previous and latest Europeans guidelines.
非酒精性脂肪性肝病（NAFLD）是肥胖和代谢综合征累及肝脏的一种病理表现。它可导致与肝脏疾病相关的残疾和死亡，并且与2型糖尿病和心血管疾病的高发病率密切相关。目前，NAFLD已成为全球最常见的慢性肝病，NAFLD诊断和治疗临床指南的制定与实施有助于改善患者的预后。本文通过对既往和最新欧洲指南的对比分析，对最新欧洲指南进行解读。
